Clinical Trial Update: Efficacy and Safety of Two Regimens of Anti-VEGF Therapy in Chinese Patients With Polypoidal Choroidal Vasculopathy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating two regimens of anti-VEGF therapy for polypoidal choroidal vasculopathy in Chinese patients, focusing on efficacy and s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polypoidal Choroidal Vasculopathy

Snippet

Sponsor: Xiaodong Sun | Conditions: Polypoidal Choroidal Vasculopathy | Phase 4 | Status: UNKNOWN